Gilles Guillemin
Cited by
Cited by
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification
GJ Guillemin, BJ Brew
Journal of Leucocyte Biology 75 (3), 388-397, 2004
Kynurenine pathway metabolites in humans: disease and healthy states
Y Chen, GJ Guillemin
International journal of tryptophan research 2, IJTR. S2097, 2009
Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats
N Braidy, GJ Guillemin, H Mansour, T Chan-Ling, A Poljak, R Grant
PloS one 6 (4), e19194, 2011
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ...
Nature 511 (7508), 184-190, 2014
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic†…
J Steiner, M Walter, T Gos, GJ Guillemin, HG Bernstein, Z Sarnyai, ...
Journal of neuroinflammation 8, 1-9, 2011
Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue
H Massudi, R Grant, N Braidy, J Guest, B Farnsworth, GJ Guillemin
Public Library of Science 7 (7), e42357, 2012
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin, SJ Kerr, GA Smythe, DG Smith, V Kapoor, PJ Armati, ...
Journal of neurochemistry 78 (4), 842-853, 2001
Expression of indoleamine 2, 3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons
GJ Guillemin, G Smythe, O Takikawa, BJ Brew
Glia 49 (1), 15-23, 2005
Quinolinic acid, the inescapable neurotoxin
GJ Guillemin
The FEBS journal 279 (8), 1356-1365, 2012
The role of reactive oxygen species in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a mini review
S Manoharan, GJ Guillemin, RS Abiramasundari, MM Essa, M Akbar, ...
Oxidative medicine and cellular longevity 2016, 2016
Indoleamine 2, 3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus
GJ Guillemin, BJ Brew, CE Noonan, O Takikawa, KM Cullen
Neuropathology and applied neurobiology 31 (4), 395-404, 2005
Characterization of the kynurenine pathway in human neurons
GJ Guillemin, KM Cullen, CK Lim, GA Smythe, B Garner, V Kapoor, ...
Journal of Neuroscience 27 (47), 12884-12892, 2007
Connecting inflammation with glutamate agonism in suicidality
S Erhardt, CK Lim, KR Linderholm, S Janelidze, D Lindqvist, ...
Neuropsychopharmacology 38 (5), 743-752, 2013
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
MD Lovelace, B Varney, G Sundaram, MJ Lennon, CK Lim, K Jacobs, ...
Neuropharmacology 112, 373-388, 2017
Neuroprotective effect of natural products against Alzheimer’s disease
MM Essa, RK Vijayan, G Castellano-Gonzalez, MA Memon, N Braidy, ...
Neurochemical research 37, 1829-1842, 2012
A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality
C Bay-Richter, KR Linderholm, CK Lim, M Samuelsson, ...
Brain, behavior, and immunity 43, 110-117, 2015
Expression of the kynurenine pathway enzymes in human microglia and macrophages
GJ Guillemin, DG Smith, GA Smythe, PJ Armati, GJ Brew
Developments in tryptophan and serotonin metabolism, 105-112, 2003
Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons
N Braidy, R Grant, S Adams, BJ Brew, GJ Guillemin
Neurotoxicity research 16, 77-86, 2009
The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation
M Favennec, B Hennart, R Caiazzo, A Leloire, L Yengo, M Verbanck, ...
Obesity 23 (10), 2066-2074, 2015
The system can't perform the operation now. Try again later.
Articles 1–20